AstraZeneca’s Covid-19 Vaccine Causes Immune Response In Young And Older Adults
A immune response that as found to be similar among older and younger adults was produced by the under-trial vaccine candidate against Covi-19 being developed by the British pharmaceutical giant AstraZeneca. The trial also fund that the potential adverse responses to the vaccine among the elderly were lower, said AstraZeneca, which is developing its potential…









